BAFNAPH
Start SIP
Invest Now
Start SIP in BAFNAPH
Performance
- Low
- ₹119
- High
- ₹124
- 52 Week Low
- ₹69
- 52 Week High
- ₹202
- Open Price₹119
- Previous Close₹124
- Volume476
- 50 DMA₹132.18
- 100 DMA₹133.23
- 200 DMA₹122.85
Investment Returns
- Over 1 Month -9.52%
- Over 3 Month -36.39%
- Over 6 Month + 32.68%
- Over 1 Year + 60.19%
Smart Investing Starts Here Start SIP with Bafna Pharmaceuticals for Steady Growth!
Bafna Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.4
- PEG Ratio
- 0.2
- Market Cap Cr
- 284
- P/B Ratio
- 3.1
- Average True Range
- 5.66
- EPS
- 4.47
- Dividend Yield
- 0
- MACD Signal
- -5.78
- RSI
- 47.7
- MFI
- 62.87
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Technicals
EMA & SMA
Current Price
₹120.00
-3.77
(-3.05%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹123.61
- 50 Day
- ₹132.18
- 100 Day
- ₹133.23
- 200 Day
- ₹122.85
Resistance and Support
124.42
- R3 132.31
- R2 129.90
- R1 126.83
- S1 121.35
- S2 118.94
- S3 115.87
Bafna Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Bafna Pharmaceuticals F&O
About Bafna Pharmaceuticals
- NSE Symbol
- BAFNAPH
- BSE Symbol
- 532989
- ISIN
- INE878I01022
Similar Stocks to Bafna Pharmaceuticals
Bafna Pharmaceuticals FAQs
Bafna Pharmaceuticals share price is ₹120 As on 13 February, 2026 | 11:14
The Market Cap of Bafna Pharmaceuticals is ₹283.9 Cr As on 13 February, 2026 | 11:14
The P/E ratio of Bafna Pharmaceuticals is 29.4 As on 13 February, 2026 | 11:14
The PB ratio of Bafna Pharmaceuticals is 3.1 As on 13 February, 2026 | 11:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.